Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Protagenic Therapeutics, Inc.\new (PTIX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Protagenic Therapeutics, Inc.\new (PTIX), most recent 12 months reported: net income $5.46M, free cash flow -$2.81M. Latest balance sheet on file: liquid cash $565.99K. From SEC filings. Others in Pharmaceutical Preparations: PROMIS NEUROSCIENCES INC. · PMV PHARMACEUTICALS, INC. · PROPANC BIOPHARMA, INC. · PRAXIS PRECISION MEDICINES, INC. · Petros Pharmaceuticals, Inc. · Pulmatrix, Inc. · Palvella Therapeutics, Inc. · Quoin Pharmaceuticals Ltd.

Stock screener

Watchlist